آنتی اکسیدان های طبیعی انار در درمان
ADHAMI, V. M., et al. 2009. Cancer chemoprevention by pomegranate: laboratory and clinical evidence. Nutr Cancer, 61, 811-5.
BARADARAN RAHIMI, V., et al. 2020. Antiinflammatory and anti-cancer activities of pomegranate and its constituent, ellagic acid: Evidence from cellular, animal, and clinical studies. Phytother Res, 34, 685-720.
BASSIRI-JAHROMI, S. 2018. Punica granatum (Pomegranate) activity in health promotion and cancer prevention. Oncol Rev, 12, 345.
EKHLASI, G., et al. 2015. Effects of Pomegranate and Orange Juice on Antioxidant Status in Non-Alcoholic Fatty Liver Disease Patients: A Randomized Clinical Trial. Int J Vitam Nutr Res, 85, 292-298.
GHOOCHANI, N., et al. 2016. The effect of pomegranate juice on clinical signs, matrix metalloproteinases and antioxidant status in patients with knee osteoarthritis. J Sci Food Agric, 96, 4377-81.
GONZALEZ-SARRIAS, A., et al. 2018. Consumption of pomegranate decreases plasma lipopolysaccharide-binding protein levels, a marker of metabolic endotoxemia, in patients with newly diagnosed colorectal cancer: a randomized controlled clinical trial. Food Funct, 9, 2617-2622.
KIM, N. D., et al. 2002. Chemopreventive and adjuvant therapeutic potential of pomegranate (Punica granatum) for human breast cancer. Breast Cancer Res Treat, 71, 203-17.
NUNEZ-SANCHEZ, M. A., et al. 2014. Targeted metabolic profiling of pomegranate polyphenols and urolithins in plasma, urine and colon tissues from colorectal cancer patients. Mol Nutr Food Res, 58, 1199-211.
NUNEZ-SANCHEZ, M. A., et al. 2017. Gene expression changes in colon tissues from colorectal cancer patients following the intake of an ellagitannin-containing pomegranate extract: a randomized clinical trial. J Nutr Biochem, 42, 126-133.
PALLER, C. J., et al. 2017. A review of pomegranate in prostate cancer. Prostate Cancer Prostatic Dis, 20, 265-270.
PANTUCK, A. J., et al. 2006. Phase II study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancer. Clin Cancer Res, 12, 4018-26.
SEERAM, N. P., et al. 2007. Pomegranate ellagitannin-derived metabolites inhibit prostate cancer growth and localize to the mouse prostate gland. J Agric Food Chem, 55, 7732-7.
STENNER-LIEWEN, F., et al. 2013. Daily Pomegranate Intake Has No Impact on PSA Levels in Patients with Advanced Prostate Cancer – Results of a Phase IIb Randomized Controlled Trial. J Cancer, 4, 597-605.
SYED, D. N., et al. 2013. Pomegranate extracts and cancer prevention: molecular and cellular activities. Anticancer Agents Med Chem, 13, 1149-61.
WANG, L., et al. 2011. Cellular and molecular mechanisms of pomegranate juice-induced anti-metastatic effect on prostate cancer cells. Integr Biol (Camb), 3, 742-54.
WANG, L., et al. 2012. Specific pomegranate juice components as potential inhibitors of prostate cancer metastasis. Transl Oncol, 5, 344-55.
WANG, L., et al. 2014. Pomegranate and its components as alternative treatment for prostate cancer. Int J Mol Sci, 15, 14949-66.
WANG, Y., et al. 2013. Pomegranate extract inhibits the bone metastatic growth of human prostate cancer cells and enhances the in vivo efficacy of docetaxel chemotherapy. Prostate.